Examedi vs Andson Biotech
Side-by-side comparison of AI visibility scores, market position, and capabilities
Santiago digital healthcare marketplace connecting LatAm patients with home labs, telemedicine, and specialist booking at $14.9M revenue; YC-backed with M&A offer received April 2025 across Chile, Mexico, Colombia.
About
Examedi is a Santiago, Chile-based digital healthcare marketplace — backed by Y Combinator with $14.9 million in revenue in 2024, having received an M&A offer in April 2025 — connecting patients across Latin America with on-demand healthcare services including lab testing at home, telemedicine consultations, home nursing visits, and specialist appointments through a marketplace model that coordinates healthcare workers, labs, and facilities. Founded in 2021 by Andres Kemeny and Juan Pablo Zepeda, Examedi serves patients, employers, health plans, and healthcare facilities throughout Chile, Mexico, Colombia, and broader Latin America as a healthcare access intermediary.
Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.
About
Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.
AI Visibility Head-to-Head
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.